The Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor?

Over the past decades the potential role of the gut microbiome and bile acids in type 2 diabetes mellitus (T2DM) has been revealed, with a special reference to low bacterial alpha diversity. Certain bile acid effects on gut bacteria concern cytotoxicity, or in the case of the microbiome, bacteriotoxicity. Reciprocally, the gut microbiome plays a key role in regulating the bile acid pool by influencing the conversion and (de)conjugation of primary bile acids into secondary bile acids. Three main groups of bacterial enzymes responsible for the conversion of bile acids are bile salt hydrolases (BSHs), hydroxysteroid dehydrogenases (HSDHs) and enzymes encoded in the bile acid inducible (Bai) operon genes. Interventions such as probiotics, antibiotics and fecal microbiome transplantation can impact bile acids levels. Further evidence of the reciprocal interaction between gut microbiota and bile acids comes from a multitude of nutritional interventions including macronutrients, fibers, prebiotics, specific individual products or diets. Finally, anatomical changes after bariatric surgery are important because of their metabolic effects. The heterogeneity of studies, diseases, bacterial species and (epi)genetic influences such as nutrition may challenge establishing specific and detailed interventions that aim to tackle the gut microbiome and bile acids.

[1]  E. Poon,et al.  The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes , 2022, Frontiers in Endocrinology.

[2]  A. Marette,et al.  Impact of Blueberry Consumption on the Human Fecal Bileacidome: A Pilot Study of Bile Acid Modulation by Freeze-Dried Blueberry , 2022, Nutrients.

[3]  F. Bäckhed,et al.  Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery , 2022, Journal of lipid research.

[4]  G. Costabile,et al.  The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs , 2022, The American journal of clinical nutrition.

[5]  Guangcong Ruan,et al.  Gut microbiota: A new target for T2DM prevention and treatment , 2022, Frontiers in Endocrinology.

[6]  Sandra L. Weber,et al.  American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. , 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  Qionglin Liang,et al.  Interactive Relationships between Intestinal Flora and Bile Acids , 2022, International journal of molecular sciences.

[8]  Annette Horstmann,et al.  Metabolic Profile and Metabolite Analyses in Extreme Weight Responders to Gastric Bypass Surgery , 2022, Metabolites.

[9]  A. Toyoda,et al.  Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species , 2022, Hepatology communications.

[10]  Casey D. Morrow,et al.  Effects of a Low-carbohydrate/High-protein Diet on Gut Microbiome Composition in Insulin Resistant Individuals with Chronic Spinal Cord Injury: Preliminary Results from a Randomized Controlled Trial. , 2022, Archives of physical medicine and rehabilitation.

[11]  A. Kural,et al.  Changes in the gut microbiota of morbidly obese patients after laparoscopic sleeve gastrectomy. , 2021, Future microbiology.

[12]  J. Walkowiak,et al.  High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review , 2021, Cells.

[13]  F. Bäckhed,et al.  Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study , 2021, Gut.

[14]  G. Rutter,et al.  Mechanisms of weight loss after obesity surgery. , 2021, Endocrine reviews.

[15]  A. Arias-Vasquez,et al.  Effects of the Mediterranean Diet or Nut Consumption On Gut Microbiota Composition and Fecal Metabolites and their Relationship With Cardiometabolic Risk Factors. , 2021, Molecular nutrition & food research.

[16]  R. Quinn,et al.  Review: microbial transformations of human bile acids , 2021, Microbiome.

[17]  J. Sholl,et al.  Reframing Nutritional Microbiota Studies To Reflect an Inherent Metabolic Flexibility of the Human Gut: a Narrative Review Focusing on High-Fat Diets , 2021, mBio.

[18]  Zhiping Chen,et al.  Clinical effects of ursodeoxycholic acid on patients with ulcerative colitis may improve via the regulation of IL-23-IL-17 axis and the changes of the proportion of intestinal microflora , 2021, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[19]  Jingyuan Fu,et al.  Gut microbiome and bile acids in obesity-related diseases. , 2021, Best practice & research. Clinical endocrinology & metabolism.

[20]  J. Walter,et al.  Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial , 2021, European Journal of Nutrition.

[21]  Bo Li,et al.  Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis , 2021, Gut microbes.

[22]  A. Reyes,et al.  Diet Quality, Food Groups and Nutrients Associated with the Gut Microbiota in a Nonwestern Population , 2020, Nutrients.

[23]  O. Pedersen,et al.  Gut microbiota in human metabolic health and disease , 2020, Nature Reviews Microbiology.

[24]  Naiman A. Khan,et al.  Avocado Consumption Alters Gastrointestinal Bacteria Abundance and Microbial Metabolite Concentrations among Adults with Overweight or Obesity: A Randomized Controlled Trial , 2020, The Journal of nutrition.

[25]  M. Hashizume,et al.  Alteration in faecal bile acids, gut microbial composition and diversity after laparoscopic sleeve gastrectomy , 2020, The British journal of surgery.

[26]  A. Zivkovic,et al.  Human gut microbiome composition and tryptophan metabolites were changed differently by fast food and Mediterranean diet in 4 days: a pilot study. , 2020, Nutrition research.

[27]  Sydney E. Dautel,et al.  Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery , 2020, npj Biofilms and Microbiomes.

[28]  Imhoi Koo,et al.  The microbiome modulating activity of bile acids , 2020, Gut microbes.

[29]  J. Walters,et al.  Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy , 2020, Scientific Reports.

[30]  Wei Chen,et al.  Rational use of prebiotics for gut microbiota alterations: Specific bacterial phylotypes and related mechanisms , 2020 .

[31]  Edoardo Pasolli,et al.  Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake , 2020, Gut.

[32]  R. Govender,et al.  Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends , 2019, Journal of epidemiology and global health.

[33]  I. García-Pérez,et al.  Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  J. Romijn,et al.  Differential effects of a 40 hour fast and bile acid supplementation on human GLP-1 and FGF19 responses. , 2019, American journal of physiology. Endocrinology and metabolism.

[35]  Evgeni Levin,et al.  Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time , 2019, Gut.

[36]  B. Patil,et al.  Review on Bile Acids: Effects of the Gut Microbiome, Interactions with Dietary Fiber, and Alterations in the Bioaccessibility of Bioactive Compounds. , 2019, Journal of agricultural and food chemistry.

[37]  J. Romijn,et al.  Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans. , 2019, Metabolism: clinical and experimental.

[38]  Tao Huang,et al.  Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial , 2019, Gut.

[39]  E. Zoetendal,et al.  Metabolic improvement in obese patients after duodenal–jejunal exclusion is associated with intestinal microbiota composition changes , 2019, International Journal of Obesity.

[40]  Thomas B. Clarke,et al.  Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection , 2019, Gut.

[41]  Nicholas A. Bokulich,et al.  Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development , 2019, Cancer medicine.

[42]  F. Shanahan,et al.  Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection , 2018, BMC Gastroenterology.

[43]  A. Lichtenstein,et al.  Walnut Consumption Alters the Gastrointestinal Microbiota, Microbially Derived Secondary Bile Acids, and Health Markers in Healthy Adults: A Randomized Controlled Trial , 2018, The Journal of nutrition.

[44]  A. Kalsbeek,et al.  Transhepatic bile acid kinetics in pigs and humans. , 2017, Clinical nutrition.

[45]  Cheng Hu,et al.  Role of gut microbiota, bile acids and their cross‐talk in the effects of bariatric surgery on obesity and type 2 diabetes , 2017, Journal of diabetes investigation.

[46]  A. Kalsbeek,et al.  Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System , 2017, Front. Neurosci..

[47]  P. Lund,et al.  In Vitro Antibacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureus , 2017, Front. Microbiol..

[48]  B. Staels,et al.  Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD. , 2017 .

[49]  Fredrik H. Karlsson,et al.  Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial , 2017, Diabetes, obesity & metabolism.

[50]  N. Maharshak,et al.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature , 2017, Digestive Diseases and Sciences.

[51]  F. Knop,et al.  Clinical relevance of the bile acid receptor TGR5 in metabolism. , 2017, The lancet. Diabetes & endocrinology.

[52]  T. Vilsbøll,et al.  Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.

[53]  Atsushi Mizoguchi,et al.  Current Understanding of Dysbiosis in Disease in Human and Animal Models , 2016, Inflammatory bowel diseases.

[54]  Michael J. Barratt,et al.  Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children , 2016, Science.

[55]  P. Hylemon,et al.  Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.

[56]  T. Pieber,et al.  Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study , 2015, PloS one.

[57]  C. Klaassen,et al.  Individual bile acids have differential effects on bile acid signaling in mice. , 2015, Toxicology and applied pharmacology.

[58]  Max Nieuwdorp,et al.  Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes , 2014, Diabetes Care.

[59]  F. Kuipers,et al.  Beyond intestinal soap—bile acids in metabolic control , 2014, Nature Reviews Endocrinology.

[60]  E. Zoetendal,et al.  Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. , 2014, Journal of hepatology.

[61]  M. Schwartz,et al.  Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans. , 2014, The Journal of clinical endocrinology and metabolism.

[62]  James Versalovic,et al.  Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation , 2013, Therapeutic advances in gastroenterology.

[63]  Tetsuya Hayashi,et al.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. , 2011, Gastroenterology.

[64]  Wen Xie,et al.  Nuclear receptor PXR, transcriptional circuits and metabolic relevance. , 2011, Biochimica et biophysica acta.

[65]  J. Auwerx,et al.  The Bile Acid Membrane Receptor TGR5: A Valuable Metabolic Target , 2011, Digestive Diseases.

[66]  B. Staels,et al.  Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes , 2011, Current diabetes reports.

[67]  T. Arora,et al.  Fermentation potential of the gut microbiome: implications for energy homeostasis and weight management. , 2011, Nutrition reviews.

[68]  M. Manns,et al.  Plasma bile acids are not associated with energy metabolism in humans , 2010, Nutrition & metabolism.

[69]  J. Donaldson,et al.  Effect of bile salts on the DNA and membrane integrity of enteric bacteria. , 2009, Journal of medical microbiology.

[70]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[71]  A. Hofmann The enterohepatic circulation of bile acids in mammals: form and functions. , 2009, Frontiers in bioscience.

[72]  A. Hofmann,et al.  Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics , 2008, Cellular and Molecular Life Sciences.

[73]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[74]  Keiko Nagata,et al.  Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria , 2006, Lipids.

[75]  J. Auwerx,et al.  Endocrine functions of bile acids , 2006, The EMBO journal.

[76]  A. Yokota,et al.  Mechanism of Growth Inhibition by Free Bile Acids in Lactobacilli and Bifidobacteria , 2006, Journal of bacteriology.

[77]  Colin Hill,et al.  Bile Salt Hydrolase Activity in Probiotics , 2006, Applied and Environmental Microbiology.

[78]  J. Casadesús,et al.  Bile-Induced DNA Damage in Salmonella enterica , 2004, Genetics.

[79]  Qiuwei Xu,et al.  Bile acid binding to sevelamer HCl. , 2002, Kidney international.

[80]  P. Hylemon,et al.  Identification and Characterization of a Bile Acid 7α-Dehydroxylation Operon in Clostridium sp. Strain TO-931, a Highly Active 7α-Dehydroxylating Strain Isolated from Human Feces , 2000, Applied and Environmental Microbiology.

[81]  H. Hara,et al.  Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. , 1999, The Journal of nutrition.

[82]  P. Hylemon,et al.  Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic ecosystems. , 1998, FEMS microbiology reviews.

[83]  W. Verstraete,et al.  Significance of bile salt hydrolytic activities of lactobacilli. , 1995, The Journal of applied bacteriology.

[84]  C. Falany,et al.  Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. , 1994, The Journal of biological chemistry.

[85]  E. Canzi,et al.  A study on the mechanism of the epimerization at C-3 of chenodeoxycholic acid by Clostridium perfringens. , 1985, The Biochemical journal.

[86]  J. Schölmerich,et al.  Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles , 1984, Hepatology.

[87]  S. Grundy,et al.  Effect of Bile Acid Conjugation Pattern on Bile Acid Metabolism in Normal Humans , 1983 .

[88]  I. Macdonald,et al.  Nad-dependent 3α- and 12α-hydroxysteroid dehydrogenase activities from eubacterwm lentum atcc no. 25559 , 1977 .

[89]  B. Filburn,et al.  The effect of bile acids on intestinal microflora. , 1972, The American journal of clinical nutrition.